candesartan cilexetil has been researched along with Stomach Neoplasms in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results showed that the growth of gastric cancer cells was significantly suppressed by treatment with AT1R antagonist." | 1.35 | Angiotensin II type 1 receptor antagonist suppress angiogenesis and growth of gastric cancer xenografts. ( Huang, W; Jiang, FX; Tian, XL; Wu, YL; Yu, LF; Zhong, J, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W | 1 |
| Wu, YL | 1 |
| Zhong, J | 1 |
| Jiang, FX | 1 |
| Tian, XL | 1 |
| Yu, LF | 1 |
1 other study available for candesartan cilexetil and Stomach Neoplasms
| Article | Year |
|---|---|
Angiotensin II type 1 receptor antagonist suppress angiogenesis and growth of gastric cancer xenografts.
Topics: Administration, Oral; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Benzim | 2008 |